Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8188138 | Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors Compounds of a certain formula I, in which R1, R2, R3, R4, R5, R6 and R7 have the meanings indicated in the description, as well as salts thereof are novel effective HDAC inhibitors. ... | 05/29/2012 |
| 8183278 | Compounds The present invention pertains generally to certain compounds of the deoxyactagardine A and B type. Such compounds are suitable for use in the treatment of microbial infections, for example Clostridium infection, such as C. perfringens, C. difficile, C. te... | 05/22/2012 |
| 8178575 | Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase IV Derivatives of azabicyclo octane presented by formula (I), the method of making them, and the compositions containing the same and the uses thereof as inhibitors of dipeptidyl peptidase IV (DPP-IV), wherein the substitutes in formula (I) have the same meanings as wh... | 05/15/2012 |
| 8168672 | Thioamide derivatives as progesterone receptor modulators Thioamide compounds, and specifically, thioamide pyrrole compounds, and preparation thereof are provided. These thioamide compounds can be used as progesterone receptor modulators, in contraception, and in the treatment of progesterone-related maladies. ... | 05/01/2012 |
| 8153679 | Radiolabelled inhibitors of the glycine 1 transporter The present invention relates to novel radiolabelled inhibitors of formula I for the Glycine 1 transporter (GlyT1), useful for the labelling and diagnostic imaging of the glycine 1 transporter functionality. wherein ... | 04/10/2012 |
| 8153678 | Process for preparing A 3-pyrrole substituted 2-indolinone malate salt The invention relates to the malic acid salt of N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide, to the use thereof as an intermediate for preparing the malic acid salt of sunitinib, and to pharmaceutical compositions comprising said malic a... | 04/10/2012 |
| 8114901 | Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride The present invention relates to crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride salt, a pharmaceutical formulation containing said salt and to methods for treating cancer and fo... | 02/14/2012 |
| 8110597 | Radioactive isotope-labeled dye compound A radioactive isotope-labeled dye compound represented by the following general formula (I): wherein R1 and R2 represent a substituent, R3 to R6 represent a substituted or unsubst... | 02/07/2012 |
| 8106088 | Fused bicyclic-substituted amines as histamine-3 receptor ligands Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands... | 01/31/2012 |
| 8093285 | Aminopiperidinyl derivatives and uses thereof This application discloses aminopiperidinyl compounds of generic Formulae I-II: or pharmaceutically acceptable salts thereof, wherein m, r, Q1, Q2, Q3, R, Ra, R1, R | 01/10/2012 |
| 8080576 | Compounds for enzyme inhibition One aspect of the invention relates to inhibitors that preferentially inhibit immunoproteasome activity over constitutive proteasome activity. In certain embodiments, the invention relates to the treatment of immune related diseases, comprising administering a compo... | 12/20/2011 |
| 8053460 | Indole derivatives having antitumor activity Indole derivatives of Formula (I+A) having antitumor and chemosensitizing activity are described. Also described are pharmaceutical compositions containing the above-mentioned compounds, for the treatment of tumors. ... | 11/08/2011 |
| 8053461 | Oxindole derivative A compound or a pharmaceutically acceptable salt thereof of the present invention is represented by the following general formula (I): [wherein, R1 to R8 may have a hydrogen atom, a halogen atom, a hyd... | 11/08/2011 |
| 8044088 | 1-acetic acid-indole derivatives with PGD2 antagonist activity Compounds of general formula (I) wherein R1 is halo or cyano; R2 is C1-C4 alkyl; and R3 is phenyl substituted with one or more substituents... | 10/25/2011 |
| 8026271 | Formulations of indol-3-yl-2-oxoacetamide compounds This invention relates to an oral formulation containing an effective amount of the compound of the following formula I: d-alpha-tocopheryl polyethylene glycol 1000 succinate (“TPGS”); and 2-(2-ethoxyethoxy)ethanol (“... | 09/27/2011 |
| 8008339 | Non-fluorescent chlorophyll catabolites The invention relates to a compound of formula (I), or a pharmacologically or cosmetically acceptable salt or derivative thereof, wherein R1 to R5 are selected from the groups R1 representing -alkyl, -vinyl, —CHOH—CH2O... | 08/30/2011 |
| 7985763 | Hepatitis C virus inhibitors A compound of the following formula: in which R1, R2, R3, U, V, T, W, X, Y, Z, m, n, p, x, y, and z are as defined herein. Also disclosed are (1) a pharmaceutical composition containing such... | 07/26/2011 |
| 7977369 | Medical compositions for intravesical treatment of bladder cancer Methods for treating bladder cancer comprising intravesicular administration of a stabilized pharmaceutical formulation comprising 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9). More specifically, the stabilized p... | 07/12/2011 |
| 7968588 | Injectable formulation of antibiotic and solution for intravenous administration thereof A pharmaceutical composition for injection comprising a depsipeptide antibiotic, WAP-8294A2, as an active ingredient, which is stable and contains WAP-8294A2 in high concentrations is provided. This composition comprises WAP-8294A2 o... | 06/28/2011 |
| 7956082 | Indole derivative having PGD2 receptor antagonist activity The present invention creates an indole derivative having DP receptor antagonistic activity and a pharmaceutical composition comprising the said compound as an active ingredient, and further a therapeutic agent for treating allergic diseases. A compound of th... | 06/07/2011 |
| 7939557 | Vascular endothelial receptor specific inhibitors The present application describes isoindoles and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful inhibitors of VEGFR. ... | 05/10/2011 |
| 7928136 | Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety The present invention relates to substituted 2-indolinone containing zinc-binding moiety based derivatives that have enhanced or unique properties as inhibitors of protein tyrosine kinase (PTK) receptors and their use in the treatment of PTK related diseases and dis... | 04/19/2011 |
| 7884126 | Indazole-heteroaryl derivatives The invention relates to novel indazole derivatives as cited in claim 1, which are inhibitors of CHK1, CHK2 and SGK kinases and can be used to treat cancer and other diseases. ... | 02/08/2011 |
| 7868035 | Therapeutic esters A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof; wherein X and Y are described herein. ... | 01/11/2011 |
| 7855223 | Method of treating inflammatory arthritis The present invention is directed to a method for treating inflammatory arthritis in a mammal. The method typically comprises administering to an animal a therapeutically effective amount of at least one compound selected from indigo, isoindigo, indirubin or derivat... | 12/21/2010 |
| 7834048 | Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor The present invention relates to a compound of the formula (I) wherein R1 is H, C1-C6-alkyl which may be substituted by C3-C6-cycloalkyl, fluorinated C | 11/16/2010 |
| 7816393 | Isoindoline compounds and methods of their use Novel isoindoline compounds are disclosed. Methods of treating, preventing and/or managing cancer, diseases and disorders associated with, or characterized by, undesired angiogenesis, and diseases and disorders mediated by PDE 4, using the compounds are also disclos... | 10/19/2010 |
| 7781477 | Therapeutic use of -(1-Indolyl)-1-indole-2-carboxamide derivatives The invention relates to therapeutic use of compounds of general formula (I): in which X1, X2, X3, X4, X5, Z1, Z2, Z3, Z4 an... | 08/24/2010 |
| 7776905 | Modulators of ATP-binding cassette transporters Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The p... | 08/17/2010 |
| 7750038 | Sulfonylated heterocycles useful for modulation of the progesterone receptor Compounds of the following structure are provided, wherein n, R1-R3 and R6-R9 are defined below, as are methods of preparing and using these compounds for contraception; treating or preventing fibroids, uterine leiomyomata... | 07/06/2010 |
| 7750037 | Antidepressant A PKB (Akt) activating agent comprising a compound represented by the formula (I): wherein R1 and R2: H, a hydrocarbon group or a heterocyclic group or R1 and R2 form a ring in co... | 07/06/2010 |
| 7741360 | Bi-aryl or aryl-heteroaryl substituted indoles The present invention relates to substituted indoles of Formula (I) useful as pharmaceutical compounds for treating respiratory disorders. ... | 06/22/2010 |
| 7741359 | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs The present invention relates to derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) having improved anti-inflammatory properties useful in the treatment of inflammation, pain and fever. More particularly, NSAIDs are derivatized with a hydrogen sulfide (H | 06/22/2010 |
| 7732478 | Methods for facilitating metabolic control The present invention provides methods for facilitating metabolic control in a subject by decreasing the level of Il-1β in the GCF. The present invention further provides methods for decreasing the level of circulating TNF in a subject. Also provided are uses of an... | 06/08/2010 |
| 7728031 | Octahydro-pyrrolo[3,4-b]pyrrole derivatives Octahydro-pyrrolo[3,4-b]pyrrole derivatives are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands, Octahydro-pyrrolo[3,4-b]pyrrole compounds, methods for using such compounds, compositions for making them, and pro... | 06/01/2010 |
| 7723373 | Indole-3-sulphur derivatives The present invention relates to substituted indoles useful as pharmaceutical compounds for treating respiratory disorders. ... | 05/25/2010 |
| 7714019 | Indole, azaindole and related heterocyclic pyrrolidine derivatives This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether u... | 05/11/2010 |
| 7691894 | Cyclohexanecarboxylic acid compound The present invention provides a VLA-4 inhibitor having high water-solubility and excellent long-term stability; i.e., sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate ... | 04/06/2010 |
| 7674815 | Heteroaryl and benzyl amide compounds Compounds of formula I processes for their preparation, their use as pharmaceuticals and to pharmaceutical compositions comprising them. ... | 03/09/2010 |
| 7666898 | Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase-related conditions, such as ... | 02/23/2010 |